Cancer, drug addiction, neurodegenerative diseases, epilepsy, immune system defects, visual pathologies, heart disease. A tiny insect, the fruit fly (Drosophila melanogaster) is providing an excellent model system to unravel these diseases and many others. More than 5,000 researchers worldwide are currently working with this organism and producing results that will have beneficial effects for health; Spain is among the leading countries for research that uses this animal model.
Twenty-six international researchers, selected on the basis of their experience in studying human disease using this animal system, will meet for the first time to present and discuss their research. The conference, to be held at the Parc Científic de Barcelona (PCB, Barcelona Science Park) on October 5-7, will focus on the use and exploitation of Drosophila as a tool to study human diseases. The event is organized by the Institute for Research in Biomedicine (IRB Barcelona) and ICREA (Institución Catalana de Investigación y Estudios Avanzados), on the initiative of Cayetano González and Marco Milán, ICREA research professors at IRB Barcelona and experts in the field of cell and developmental biology.
The role of the fly
Studies using Drosophila date back to the last century and have provided valuable insight into the fundamental principles of biology and genetics. Only in recent years, however, and thanks in large part to the discovery of the high degree of homology between the genetic make-up of flies and vertebrates, has Drosophila emerged as one of the most effective model systems to analyze the function of genes whose human homologues play a crucial role in many diseases, including neurological, metabolic and developmental disorders, cancer, cardiovascular failure, and pathologies of the visual, auditory and immune systems.
A growing number of laboratories are modelling human diseases in the fly. These models are providing the basic tools for genetic and pharmacological tests that aim to identify target genes as well as compounds that may lead to future therapies. Moreover, more and more companies that exploit this model system are being established worldwide. In order to highlight the potential of applied science, the organizers of this conference have invited two of the main pharmaceutical companies currently making considerable investments into research using Drosophila: En Vivo Pharmaceuticals, in the US, and VASTox in Oxford, UK.
Drug addiction, cancer and heart disease
“What can a fly tell us about drug addiction?” is the title of a talk by the University of California's Ulrike Heberlein, a pioneer in drug abuse research using Drosophila. Her research group focuses on the possible links between genes and behaviour caused by drug abuse and the mechanisms that regulate responses to psychostimulants such as alcohol, cocaine and nicotine.
Drosophila is a key tool for studying certain aspects of cancer, and research into the development and proliferation of tumours will be a main topic of the conference. Ross Cagan, from the University of Washington, will present his recent research on a drug that has a direct effect on tumour progression. Cayetano González, from IRB Barcelona, will discuss his work on stem cells and cancer; and Ginés Morata, from the Universidad Autónoma de Madrid, will address apoptosis and tumourous transformation.
Heart disease is another topic that has recently been added to the list of diseases studied using Drosophila. Rolf Bodmer, from The Burnham Institute in the US, has begun to use this model to study arrhythmias and heart failure. His presentation “Arrhythmias and cardiac failure: the Drosophila model of congenital heart disease” will highlight the latest results in this field.
Sarah Sherwood | alfa
Unique genome architectures after fertilisation in single-cell embryos
30.03.2017 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH
Transport of molecular motors into cilia
28.03.2017 | Aarhus University
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
30.03.2017 | Health and Medicine
30.03.2017 | Health and Medicine
30.03.2017 | Medical Engineering